About: postmenopausal osteoporosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: postmenopausal osteoporosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

human disease

Attributes	Values
rdf:type	Item
description	human disease (en) хвороба людини (uk)
Experimental Factor Ontology ID	wds:Q55950294-7688CFC7-6CC6-4F75-A7D0-2802A6120D7A
health specialty	wds:Q55950294-A16101D6-7ABD-4E7B-ABCE-8DB080732754 wds:Q55950294-E2CA8213-339D-4FA6-BF58-7B706970C356
drug or therapy used for treatment	wds:Q55950294-5491E060-E913-4FFE-B536-76D45367186D wds:Q55950294-58C39FA2-DC05-4A53-89E5-EDFA873893FE wds:Q55950294-C2913A30-DC0A-4B1E-B27D-ACD98369EA4D wds:Q55950294-FBDB8E6C-96E6-4C36-9360-4006CC4D5A31
Mondo ID	wds:Q55950294-82696AEA-4BFF-4F35-829E-991D8065461E
Mondo ID	http://purl.obolibrary.org/obo/MONDO_0008159
Experimental Factor Ontology ID	0003854
health specialty	rheumatology endocrinology
drug or therapy used for treatment	wd:Q166825 teriparatide denosumab zoledronic acid monohydrate
Mondo ID	MONDO_0008159
rdfs:label	ostéoporose post-ménopausique (fr) pomenopavzna osteoporoza (sl) postmenopausal osteoporose (nn) postmenopausal osteoporosis (en)
skos:prefLabel	ostéoporose post-ménopausique (fr) pomenopavzna osteoporoza (sl) postmenopausal osteoporose (nn) postmenopausal osteoporosis (en)
name	ostéoporose post-ménopausique (fr) pomenopavzna osteoporoza (sl) postmenopausal osteoporose (nn) postmenopausal osteoporosis (en)
instance of	wds:Q55950294-DE7F8E99-37E3-4AE2-A65A-BFA3B0EFBEDC
instance of	disease
subclass of	wds:Q55950294-43368390-4867-2416-1b5a-465fb0f37f60
subclass of	osteoporosis
skos:altLabel	Bone Mineral Density Quantitative Trait Locus (en) Osteoporosis, Postmenopausal (en) postmenopausal beinskøyrheit (nn)
UMLS CUI	wds:Q55950294-0DD890B1-478B-4B73-9B12-2C879B447B75 wds:Q55950294-187751B8-EB64-4D2A-81FB-EF31C23DDA6F wds:Q55950294-58804C3B-D0F1-443F-A56E-0DA7CB0F7252 wds:Q55950294-8E5F8D70-C0CC-41F7-B83F-BB53239F8FCF
MeSH descriptor ID	wds:Q55950294-617BEAFA-714A-4B2D-AA04-85C95E96609F
MeSH tree code	wds:Q55950294-17612301-4ab0-8be6-fd1d-65aff0fda012 wds:Q55950294-676fb57d-4438-1845-c79c-13eca28db2cc
ICD-11 ID (MMS)	wds:Q55950294-22ccdfcc-8868-4c34-ac88-1b9ad73283d5
ICD-11 (foundation)	wds:Q55950294-B2C19629-A699-4A7A-A6C1-01B3C5342B96
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D015663
MeSH tree code	http://id.nlm.nih.gov/mesh/C05.116.198.579.610 http://id.nlm.nih.gov/mesh/C18.452.104.579.610
UMLS CUI	C0029459 C0029456 C0029458 C2674640
MeSH descriptor ID	D015663
MeSH tree code	C05.116.198.579.610 C18.452.104.579.610
ICD-11 ID (MMS)	FB83.11
ICD-11 (foundation)	123797893
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q55950294
is main subject of	Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials Influence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosis Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Diagnosis of postmenopausal osteoporosis: reviews in endocrine and metabolic disorders Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force Long-term efficacy of cyclical etidronate therapy in postmenopausal osteoporosis Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative Assessing the content and quality of information on the treatment of postmenopausal osteoporosis on the World Wide Web. Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years. Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis Postmenopausal osteoporosis - clinical, biological and histopathological aspects. Identification of women at risk for developing postmenopausal osteoporosis with vertebral fractures: role of history and single photon absorptiometry American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Postmenopausal osteoporosis risk management in primary care: how well does it adhere to national practice guidelines? Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis Risedronate for the prevention and treatment of postmenopausal osteoporosis Intermittent cyclical etidronate treatment of postmenopausal osteoporosis Postmenopausal osteoporosis: the role of immune system cells Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis Effect of Qing'e formula on circulating sclerostin levels in patients with postmenopausal osteoporosis [Polymorphism of the gene for vitamin D receptor, bone mass, and bone turnover in women with postmenopausal osteoporosis] Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis Mathematical modeling of postmenopausal osteoporosis and its treatment by the anti-catabolic drug denosumab. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group Treatment of postmenopausal osteoporosis Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial Intravenous zoledronate for postmenopausal osteoporosis Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®). Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software